Medical devices, healthcare technology and the business of care
510(k) clearance · K254198

Trexo Theo

Trexo Robotics, Inc. · Decision date Sep 2, 2026

MEDTECHLEDGER EXPLANATIONK254198

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for Trexo Theo, a powered lower extremity exoskeleton from Trexo Robotics, Inc., under 21 CFR 890.3480, Class II, product code PHL, in the Physical Medicine specialty. The decision date is September 2, 2026; the public record lists the application as received December 23, 2025, while the clearance letter cites a July 31, 2026 dated submission received August 3, 2026. SESE is a 510(k) clearance, not a PMA approval.

The summary describes a battery-powered, wearable lower-limb exoskeleton assisting hip and knee motion, used with a rigid, four-wheeled, lockable walker frame and controlled by a trained operator through a tablet. Named predicates are Cyberdyne's HAL-ML (K233695) and Rewalk P6.0 (K221696). The stated indication covers ambulatory functions in patients 12 years and older with cerebral palsy, in community and clinical settings under certified supervision, and excludes sports and stair climbing. The record does not resolve the differing submission dates or provide independent clinical findings.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Physical Medicine
Decision date
Sep 2, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K254198
Regulatory pathway
510(k) premarket notification
Product code
PHL
Decision code
SESE
Decision date
Sep 2, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Powered Exoskeleton.

Product code
PHL
FDA device class
2

FDA decision timeline

  1. K254198 received

    Application receipt date recorded by FDA.

  2. K254198 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Trexo Robotics, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Mississauga

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records